• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

MCOs continue to abandon Medicare

Article

Although fewer seniors will be forced to switch to new coverage optionsnext year than did last January, MCOs still are dropping out of the Medicare+Choiceprogram at a disturbing rate. Aggressive efforts by Tom Scully, administratorof the Centers for Medicare & Medicaid Services (CMS), encouraged somehealth plans to stick with the program for now, but dozens of MCOs abandonedor curtailed service areas when they filed cost proposals for contract year2002 in September. Consequently, 536,000 seniors will have to find new coverageby January, much less than the 934,000 affected by MCO departures last year.But many of those plans that remain are reducing optional benefits or raisingpremiums in order to continue coverage.

Related Content
© 2024 MJH Life Sciences

All rights reserved.